Mediolanum farmaceutici S.p.A Company Profile

04:16 EDT 19th June 2018 | BioPortfolio



Via S.G. Cottolengo, 15


Phone: 39 0289132.1
Fax: 39 0289132.295

News Articles [16 Associated News Articles listed on BioPortfolio]

Mediolanum farmaceutici SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13032018] Prices from USD $250

SummaryMediolanum farmaceutici SpA Mediolanum is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in the...

MA granted for drug tested in just 34 patients

An absence of comprehensive data did not prevent Italian family-owned drugmaker Chiesi Farmaceutici from…

Pending EC decision: CHF 5993 Chiesi Farmaceutici S.p.A., beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium, Opinion date: 22-Feb-2018

Human medicines European public assessment report (EPAR): Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.), beclometasone / formoterol / glycopyrronium bromide, Revision: 0, Authorised

Excelencia farmacéutica italiana en I+D durante el 33rd Congress of the European Association ...

     (Logo: Fidia Farmaceutici anunció hoy los resultados positivos de un ensayo en fase II en el que se evalúa la efica...

Pharmazeutische F&E-Spitzenleistung aus Italien beim 33. ...

     (Logo: Fidia Farmaceutici gab heute die positiven Ergebnisse einer Phase-II-Studie bekannt, in der Wirksamkeit und Vertr...

Excellence italienne en RD pharmaceutique au 33ème Congrès de l'Association européenne d'urologie

     (Logo: Fidia Farmaceutici a annoncé aujourd'hui les résultats positifs d'un essai de phase II évaluant l'efficacit...

EU Panel Backs Two Triple Combo Drugs for COPD Maintenance

CHF 5993 and Trydonis, from Chiesi Farmaceutici SpA, combine a glucocorticoid, a long-acting beta-2 receptor agonist, and a long-acting muscarinic antagonist. International Approvals

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Curosurf [Cornerstone Therapeutics Inc.]

CUROSURF (poractant alfa)Intratracheal Suspension

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Triticum vulgare extract exerts an anti-inflammatory action in two in vitro models of inflammation in microglial cells.

Triticum vulgare has been extensively used in traditional medicine thanks to its properties of accelerating tissue repair. The specific extract of Triticum vulgare manufactured by Farmaceutici Damor (...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Evaluation of the filler performance on the nasolabial folds of Aliaxin® EV with and without lidocaine 0.3%: comparison within subjects (half face method)

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Aim of the study is to evaluate the re-volumizing performance and the duration effect of the product Aliaxin (new trademark) in women aged 40-65 years with midface volume defects due to ag...

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial

The rational of intra-articular viscosupplementation is based on both the biological and mechanical properties of HA, which exerts positive effects on the modulation of the entire joint en...

Companies [6 Associated Companies listed on BioPortfolio]

Mediolanum farmaceutici S.p.A


Fidia Farmaceutici

Fidia Farmaceutici is part of Fidia Pharma Group, an Italian multinational company, with R&D, manufacturing and sales capabilities, and an extensive product portfolio mainly based...

Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

Dompé Farmaceutici S.p.A.

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular patholog...

Fidia Pharma USA Inc.

Fidia Pharma USA Inc., headquartered in Parsippany, NJ, is a wholly-owned subsidiary of the multinational pharmaceutical company Fidia Farmaceutici SpA. Fidia Pharma USA is focuse...

More Information about "Mediolanum farmaceutici S.p.A" on BioPortfolio

We have published hundreds of Mediolanum farmaceutici S.p.A news stories on BioPortfolio along with dozens of Mediolanum farmaceutici S.p.A Clinical Trials and PubMed Articles about Mediolanum farmaceutici S.p.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mediolanum farmaceutici S.p.A Companies in our database. You can also find out about relevant Mediolanum farmaceutici S.p.A Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record